Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2024-04-24 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
2024年度向部分金融机构申请授信、融资事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding its plans to apply for credit and financing from various financial institutions for the year 2024. It details the amounts, types of financing, and terms but does not contain financial statements or results. The document length is short (1267 characters) and it is clearly an update on financing activities rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-04-24 Chinese
中粮科技2023ESG报告
Regulatory Filings
2024-04-24 Chinese
年度股东大会通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2023 Annual General Meeting (AGM) of 中粮生物科技股份有限公司. It includes details about the meeting time, location, voting procedures, agenda items, and proxy voting instructions. The document does not contain financial statements or detailed financial analysis but rather serves as an announcement and invitation to shareholders to participate in the AGM. The document length is 4274 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-24 Chinese
2023年度独立董事述职报告（李世辉）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2023" for a company. It details the independent director's attendance at board meetings, opinions on various company matters, and oversight activities during the year. It does not contain financial statements or comprehensive financial performance data. It is a report on the independent director's duties and opinions rather than a full annual report or audit report. This type of document fits best under Board/Management Information (MANG), as it relates to board members' activities and governance roles.
2024-04-24 Chinese
监事会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of resolutions passed at the eighth session of the seventh Supervisory Board meeting of the company. It includes voting results on various reports and proposals such as the 2023 annual supervisory board work report, the 2023 annual report full text and summary, internal control evaluation report, financial settlement report, profit distribution proposal, 2024 business plan, 2024 Q1 report, stock incentive plan, and capital reduction proposal. The document is relatively short (1754 characters) and primarily serves as a meeting resolution announcement rather than containing the full reports themselves. It includes official voting results and approvals by the supervisory board, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not the full annual report or financial report, nor is it a proxy solicitation or management report. Therefore, the best classification is DVA with high confidence.
2024-04-24 Chinese
关于限制性股票激励计划授予股票第三个解锁期解锁条件未成就暨回购注销限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the company's restricted stock incentive plan, specifically about the third unlocking period conditions not being met and the subsequent repurchase and cancellation of restricted shares. It includes detailed information about the stock incentive plan, approval procedures, unlocking conditions, repurchase quantities, prices, and the impact on the company's share capital. It also contains opinions from the board's remuneration and assessment committee, independent directors, and the supervisory board regarding the repurchase. The document is an official announcement about a share repurchase related to the company's stock incentive plan, not a full financial report or management discussion. It fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares, including repurchases related to stock incentive plans.
2024-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.